메뉴 건너뛰기




Volumn 115, Issue 5, 2015, Pages 705-712

Risk stratification for bladder recurrence of upper urinary tract urothelial carcinoma after radical nephroureterectomy

(25)  Ishioka, Junichiro a   Saito, Kazutaka a   Kijima, Toshiki a   Nakanishi, Yasukazu a   Yoshida, Soichiro a   Yokoyama, Minato a   Matsuoka, Yoh a   Numao, Noboru a   Koga, Fumitaka a   Masuda, Hitoshi a   Fujii, Yasuhisa a   Sakai, Yasuyuki b   Arisawa, Chizuru c   Okuno, Tetsuo d   Nagahama, Katsuhi e   Kamata, Shigeyoshi f   Sakura, Mizuaki g   Yonese, Junji g   Morimoto, Shinji h   Noro, Akira i   more..


Author keywords

bladder recurrence; radical nephroureterectomy; upper tract urothelial carcinoma

Indexed keywords

PLATINUM COMPLEX;

EID: 84927913063     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12707     Document Type: Article
Times cited : (45)

References (32)
  • 1
    • 38349018490 scopus 로고    scopus 로고
    • Bladder cancer following upper tract urothelial carcinoma
    • Kauffman EC, Raman JD,. Bladder cancer following upper tract urothelial carcinoma. Expert Rev Anticancer Ther 2008; 8: 75-85
    • (2008) Expert Rev Anticancer Ther , vol.8 , pp. 75-85
    • Kauffman, E.C.1    Raman, J.D.2
  • 2
    • 79952038276 scopus 로고    scopus 로고
    • Bladder recurrence after surgery for upper urinary tract urothelial cell carcinoma: Frequency, risk factors, and surveillance
    • Azémar MD, Comperat E, Richard F, Cussenot O, Rouprêt M,. Bladder recurrence after surgery for upper urinary tract urothelial cell carcinoma: frequency, risk factors, and surveillance. Urol Oncol 2011; 29: 130-136
    • (2011) Urol Oncol , vol.29 , pp. 130-136
    • Azémar, M.D.1    Comperat, E.2    Richard, F.3    Cussenot, O.4    Rouprêt, M.5
  • 3
    • 37549072095 scopus 로고    scopus 로고
    • National Comprehensive Cancer Network Homepage Available at:. Accessed December 2012
    • National Comprehensive Cancer Network Homepage. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Bladder Cancer. 2012. Available at: http://www.nccn.org/professionals/physician-gls/f-guidelines.asp. Accessed December 2012
    • (2012) NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Bladder Cancer
  • 4
    • 80052266263 scopus 로고    scopus 로고
    • British Association of Urological Surgeons Section of Oncology. Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: A prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C Trial)
    • O'Brien T, Ray E, Singh R, et-al. British Association of Urological Surgeons Section of Oncology. Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C Trial). Eur Urol 2011; 60: 703-710
    • (2011) Eur Urol , vol.60 , pp. 703-710
    • O'Brien, T.1    Ray, E.2    Singh, R.3
  • 5
    • 1542532754 scopus 로고    scopus 로고
    • A proportional hazards model for the subdistribution of a competing risk
    • Fine JP, Gray RJ,. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94: 496-509
    • (1999) J Am Stat Assoc , vol.94 , pp. 496-509
    • Fine, J.P.1    Gray, R.J.2
  • 6
    • 80053334361 scopus 로고    scopus 로고
    • Propensity score matching, competing risk analysis, and a competing risk nomogram: Some guidance for urologists may be in place
    • Roobol MJ, Heijnsdijk EA,. Propensity score matching, competing risk analysis, and a competing risk nomogram: some guidance for urologists may be in place. Eur Urol 2010; 60: 931
    • (2010) Eur Urol , vol.60 , pp. 931
    • Roobol, M.J.1    Heijnsdijk, E.A.2
  • 7
    • 70349741107 scopus 로고    scopus 로고
    • Gasless single-port access endoscopic surgery in urology: Minimum incision endoscopic surgery, MIES
    • Kihara K, Kawakami S, Fujii Y, et-al. Gasless single-port access endoscopic surgery in urology: minimum incision endoscopic surgery, MIES. Int J Urol 2009; 16: 791-800
    • (2009) Int J Urol , vol.16 , pp. 791-800
    • Kihara, K.1    Kawakami, S.2    Fujii, Y.3
  • 8
    • 84855207840 scopus 로고    scopus 로고
    • Gasless two port access total nephroureterectomy: MIES total nephroureterectomy
    • Saito K, Kihara K, Kawakami S, et-al. Gasless two port access total nephroureterectomy: MIES total nephroureterectomy. Eur Urol Suppl 2010; 9: 335
    • (2010) Eur Urol Suppl , vol.9 , pp. 335
    • Saito, K.1    Kihara, K.2    Kawakami, S.3
  • 11
    • 84944363874 scopus 로고
    • Evaluating the yield of medical tests
    • Harrell FE Jr, Califf RM, Pryor DB,. Evaluating the yield of medical tests. JAMA 1982; 247: 2543-2546
    • (1982) JAMA , vol.247 , pp. 2543-2546
    • Harrell, Jr.F.E.1    Califf, R.M.2    Pryor, D.B.3
  • 12
    • 33750905259 scopus 로고    scopus 로고
    • Decision curve analysis: A novel method for evaluating prediction models
    • Vickers AJ, Elkin EB,. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making 2006; 26: 565-574
    • (2006) Med Decis Making , vol.26 , pp. 565-574
    • Vickers, A.J.1    Elkin, E.B.2
  • 13
    • 58149269742 scopus 로고    scopus 로고
    • Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, predictionmodels and molecular markers
    • Vickers AJ, Cronin AM, Elkin EB, Gonen M,. Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, predictionmodels and molecular markers. BMC Med Inform Decis Mak 2008; 8: 53
    • (2008) BMC Med Inform Decis Mak , vol.8 , pp. 53
    • Vickers, A.J.1    Cronin, A.M.2    Elkin, E.B.3    Gonen, M.4
  • 14
    • 84866899421 scopus 로고    scopus 로고
    • Development of a nomogram incorporating serum C-reactive protein level to predict overall survival of patients with advanced urothelial carcinoma and its evaluation by decision curve analysis
    • Ishioka J, Saito K, Sakura M, et-al. Development of a nomogram incorporating serum C-reactive protein level to predict overall survival of patients with advanced urothelial carcinoma and its evaluation by decision curve analysis. Br J Cancer 2012; 107: 1031-1036
    • (2012) Br J Cancer , vol.107 , pp. 1031-1036
    • Ishioka, J.1    Saito, K.2    Sakura, M.3
  • 15
    • 43049095391 scopus 로고    scopus 로고
    • Independent predictors of metachronous bladder transitional cell carcinoma (TCC) after nephroureterectomy for TCC of the upper urinary tract
    • Novara G, De Marco V, Dalpiaz O, et-al. Independent predictors of metachronous bladder transitional cell carcinoma (TCC) after nephroureterectomy for TCC of the upper urinary tract. BJU Int 2008; 101: 1368-1374
    • (2008) BJU Int , vol.101 , pp. 1368-1374
    • Novara, G.1    De Marco, V.2    Dalpiaz, O.3
  • 16
    • 65049091900 scopus 로고    scopus 로고
    • Laparoscopic radical nephroureterectomy: A multicenter analysis in Japan
    • Kamihira O, Hattori R, Yamaguchi A, et-al. Laparoscopic radical nephroureterectomy: a multicenter analysis in Japan. Eur Urol 2009; 55: 1397-1407
    • (2009) Eur Urol , vol.55 , pp. 1397-1407
    • Kamihira, O.1    Hattori, R.2    Yamaguchi, A.3
  • 17
    • 84873140268 scopus 로고    scopus 로고
    • Intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinomas: Predictors and impact on subsequent oncological outcomes from a national multicenter study
    • Xylinas E, Colin P, Audenet F, et-al. Intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinomas: predictors and impact on subsequent oncological outcomes from a national multicenter study. World J Urol 2013; 31: 61-68
    • (2013) World J Urol , vol.31 , pp. 61-68
    • Xylinas, E.1    Colin, P.2    Audenet, F.3
  • 18
    • 84880701387 scopus 로고    scopus 로고
    • Gender as a significant predictor of intravesical recurrence in patients with urothelial carcinoma of the upper urinary tract following nephroureterectomy
    • Kusuda Y, Miyake H, Terakawa T, et-al. Gender as a significant predictor of intravesical recurrence in patients with urothelial carcinoma of the upper urinary tract following nephroureterectomy. Urol Oncol 2013; 31: 899-903
    • (2013) Urol Oncol , vol.31 , pp. 899-903
    • Kusuda, Y.1    Miyake, H.2    Terakawa, T.3
  • 19
    • 38649125214 scopus 로고    scopus 로고
    • Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract
    • Terakawa T, Miyake H, Muramaki M, et-al. Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract. Urology 2008; 71: 123-127
    • (2008) Urology , vol.71 , pp. 123-127
    • Terakawa, T.1    Miyake, H.2    Muramaki, M.3
  • 20
    • 55649120887 scopus 로고    scopus 로고
    • Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients
    • Li CC, Chang TH, Wu WJ, et-al. Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients. Eur Urol 2008; 54: 1127-1134
    • (2008) Eur Urol , vol.54 , pp. 1127-1134
    • Li, C.C.1    Chang, T.H.2    Wu, W.J.3
  • 21
    • 33748535074 scopus 로고    scopus 로고
    • Kaplan-Meier methods yielded misleading results in competing risk scenarios
    • Southern DA, Faris PD, Brant R, et-al. Kaplan-Meier methods yielded misleading results in competing risk scenarios. J Clin Epidemiol 2006; 59: 1110-1114
    • (2006) J Clin Epidemiol , vol.59 , pp. 1110-1114
    • Southern, D.A.1    Faris, P.D.2    Brant, R.3
  • 22
    • 0026598808 scopus 로고
    • Bladder cancer - Field versus clonal origin
    • Harris AL, Neal DE,. Bladder cancer-field versus clonal origin. N Engl J Med 1992; 326: 759-761
    • (1992) N Engl J Med , vol.326 , pp. 759-761
    • Harris, A.L.1    Neal, D.E.2
  • 23
    • 28544432309 scopus 로고    scopus 로고
    • Origin of multifocal carcinomas of the bladder and upper urinary tract: Molecular analysis and clinical implications
    • Habuchi T,. Origin of multifocal carcinomas of the bladder and upper urinary tract: molecular analysis and clinical implications. Int J Urol 2005; 12: 709-716
    • (2005) Int J Urol , vol.12 , pp. 709-716
    • Habuchi, T.1
  • 24
    • 68949107975 scopus 로고    scopus 로고
    • Primary urothelial carcinoma of the upper tract: Important clinicopathological factors predicting bladder recurrence after surgical resection
    • Huang WW, Huang HY, Liao AC, et-al. Primary urothelial carcinoma of the upper tract: important clinicopathological factors predicting bladder recurrence after surgical resection. Pathol Int 2009; 59: 642-649
    • (2009) Pathol Int , vol.59 , pp. 642-649
    • Huang, W.W.1    Huang, H.Y.2    Liao, A.C.3
  • 25
    • 79959191452 scopus 로고    scopus 로고
    • Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma
    • Fritsche HM, Novara G, Burger M, et-al. Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma. Urol Oncol 2012; 30: 666-672
    • (2012) Urol Oncol , vol.30 , pp. 666-672
    • Fritsche, H.M.1    Novara, G.2    Burger, M.3
  • 26
    • 13844266069 scopus 로고    scopus 로고
    • Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract
    • Matsui Y, Utsunomiya N, Ichioka K, et-al. Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract. Urology 2005; 65: 279-283
    • (2005) Urology , vol.65 , pp. 279-283
    • Matsui, Y.1    Utsunomiya, N.2    Ichioka, K.3
  • 27
    • 32944465832 scopus 로고    scopus 로고
    • Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials
    • Sylvester RJ, van der Meijden AP, Oosterlinck W, et-al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 2006; 49: 466-477
    • (2006) Eur Urol , vol.49 , pp. 466-477
    • Sylvester, R.J.1    Van Der Meijden, A.P.2    Oosterlinck, W.3
  • 28
    • 35748954340 scopus 로고    scopus 로고
    • Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically
    • Saito K, Kawakami S, Fujii Y, et-al. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically. J Urol 2007; 178: 2291-2296
    • (2007) J Urol , vol.178 , pp. 2291-2296
    • Saito, K.1    Kawakami, S.2    Fujii, Y.3
  • 29
    • 59149090103 scopus 로고    scopus 로고
    • Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma
    • Kikuchi E, Margulis V, Karakiewicz PI, et-al. Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma. J Clin Oncol 2009; 27: 612-618
    • (2009) J Clin Oncol , vol.27 , pp. 612-618
    • Kikuchi, E.1    Margulis, V.2    Karakiewicz, P.I.3
  • 30
    • 78349269578 scopus 로고    scopus 로고
    • Concomitant carcinoma in situ and tumour size are prognostic factors for bladder recurrence after nephroureterectomy for upper tract transitional cell carcinoma
    • Pieras E, Frontera G, Ruiz X, Vicens A, Ozonas M, Pizá P,. Concomitant carcinoma in situ and tumour size are prognostic factors for bladder recurrence after nephroureterectomy for upper tract transitional cell carcinoma. BJU Int 2010; 106: 1319-1323
    • (2010) BJU Int , vol.106 , pp. 1319-1323
    • Pieras, E.1    Frontera, G.2    Ruiz, X.3    Vicens, A.4    Ozonas, M.5    Pizá, P.6
  • 31
    • 79960698217 scopus 로고    scopus 로고
    • External validation and applicability of the EORTC risk tables for non-muscle-invasive bladder cancer
    • Hernández V, De La Peña E, Martin MD, et-al. External validation and applicability of the EORTC risk tables for non-muscle-invasive bladder cancer. World J Urol 2011; 29: 409-414
    • (2011) World J Urol , vol.29 , pp. 409-414
    • Hernández, V.1    De La Peña, E.2    Martin, M.D.3
  • 32
    • 79961012135 scopus 로고    scopus 로고
    • The EORTC tables overestimate the risk of recurrence and progression in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: External validation of the EORTC risk tables
    • Fernandez-Gomez J, Madero R, Solsona E, et-al. The EORTC tables overestimate the risk of recurrence and progression in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: external validation of the EORTC risk tables. Eur Urol 2011; 60: 423-430
    • (2011) Eur Urol , vol.60 , pp. 423-430
    • Fernandez-Gomez, J.1    Madero, R.2    Solsona, E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.